Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 4
1976 2
1978 3
1980 2
1981 3
1982 1
1983 1
1985 2
1986 1
1987 1
1988 1
1991 1
2000 1
2006 1
2008 1
2012 1
2013 1
2015 1
2017 7
2018 6
2019 3
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial.
Saleem MD, Negus D, Feldman SR. Saleem MD, et al. J Dermatolog Treat. 2018 Feb;29(1):32-35. doi: 10.1080/09546634.2017.1331027. Epub 2017 May 30. J Dermatolog Treat. 2018. PMID: 28504031 Clinical Trial.
Alternative formulations have gained popularity due to their ease of application, improved adherence and efficacy. OBJECTIVE: To evaluate the efficacy of topical desoximetasone 0.25% spray formulation in extensive psoriasis. METHODS: This multicenter, double-blinded, rando …
Alternative formulations have gained popularity due to their ease of application, improved adherence and efficacy. OBJECTIVE: To evaluate th …
Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization.
Nadkarni A, Saleem MD, Feldman SR. Nadkarni A, et al. J Drugs Dermatol. 2017 Aug 1;16(8):755-758. J Drugs Dermatol. 2017. PMID: 28809990 Clinical Trial.

OBJECTIVE: To evaluate the irritation and sensitization potential of topical desoximetasone spray formulation.</p> <p>METHODS: A multicenter, double-blinded, randomized, controlled study assessed the irritancy and sensitization of 0.25% and …

OBJECTIVE: To evaluate the irritation and sensitization potential of topical desoximetasone spray formulation.&lt …

Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis.
Saleem MD, Feldman SR. Saleem MD, et al. J Dermatolog Treat. 2018 Feb;29(1):36-38. doi: 10.1080/09546634.2017.1329508. Epub 2017 May 31. J Dermatolog Treat. 2018. PMID: 28494626 Clinical Trial.
OBJECTIVE: To evaluate the potential for hypothalamic-pituitary-adrenal axis suppression and efficacy of topical desoximetasone 0.25% spray formulation in patients with extensive psoriasis. ...Two groups of 12 adults with moderate to severe plaque-type psoriasis were treat …
OBJECTIVE: To evaluate the potential for hypothalamic-pituitary-adrenal axis suppression and efficacy of topical desoximetasone 0.25% …
Calcipotriol ointment shows comparable efficacy to topical steroids in chronic hand eczema.
Juntongjin P, Pongprasert R. Juntongjin P, et al. Dermatol Ther. 2019 Jul;32(4):e12956. doi: 10.1111/dth.12956. Epub 2019 May 20. Dermatol Ther. 2019. PMID: 31070845 Clinical Trial.
This study aimed to evaluate the efficacy and safety of calcipotriol ointment compared to desoximetasone ointment in the treatment of CHE. Patch testing was performed in all recruited subjects. ...Mild scaling and mild dryness were the most common reactions found with calc …
This study aimed to evaluate the efficacy and safety of calcipotriol ointment compared to desoximetasone ointment in the treatment of …
Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis.
Hebert AA, Koo J, Fowler J, Berman B, Rosenberg C, Levitt J. Hebert AA, et al. Cutis. 2006 Nov;78(5):357-63. Cutis. 2006. PMID: 17186796 Clinical Trial.
Long-term in vitro compatibility of desoximetasone and tacrolimus ointments prompted the current trial in humans. ...Combination treatment with desoximetasone and tacrolimus offered increased efficacy and tolerability over tacrolimus alone in patients with atopic de …
Long-term in vitro compatibility of desoximetasone and tacrolimus ointments prompted the current trial in humans. ...Combination trea …
Efficacy and Safety of Desoximetasone 0.25% Spray in Adult Atopic Dermatitis Subjects: Pilot Study.
Hoffman LK, Kircik L. Hoffman LK, et al. J Drugs Dermatol. 2017 Sep 1;16(9):919-922. J Drugs Dermatol. 2017. PMID: 28915287 Clinical Trial.
STUDY DESIGN: A single-center, open labeled pilot study was conducted to investigate the efficacy and safety of desoximetasone 0.25% spray for pruritus in adult atopic dermatitis patients. ...Given its efficacy and convenience as a spray, desoximetasone 0.25% spray …
STUDY DESIGN: A single-center, open labeled pilot study was conducted to investigate the efficacy and safety of desoximetasone 0.25% …
Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray.
Hogue L, Cardwell LA, Roach C, Felix KH, Oussedik E, Richardson I, Feldman SR. Hogue L, et al. J Cutan Med Surg. 2019 Mar/Apr;23(2):157-163. doi: 10.1177/1203475418818082. Epub 2018 Dec 17. J Cutan Med Surg. 2019. PMID: 30556414 Clinical Trial.
Six participants were randomized to each of 2 groups of desoximetasone 0.25% spray alone (n = 6) or desoximetasone spray plus twice-daily phone call reminders to use the medication. Disease severity was assessed. RESULTS: In treatment-resistant Ps patients, desox
Six participants were randomized to each of 2 groups of desoximetasone 0.25% spray alone (n = 6) or desoximetasone spray plus …
Desoximetasone 0.25% Spray for the Relief of Scaling in Adults With Plaque Psoriasis.
Keegan BR. Keegan BR. J Drugs Dermatol. 2015 Aug;14(8):835-40. J Drugs Dermatol. 2015. PMID: 26267727 Clinical Trial.
At the baseline visit, the mean proportions of BSA affected by psoriasis were 17% (range 10% to 86%) in the desoximetasone 0.25% spray group and 16% (range 10% to 70%) in the vehicle spray group. ...This demonstrates that desoximetasone 0.25% spray provided fast and …
At the baseline visit, the mean proportions of BSA affected by psoriasis were 17% (range 10% to 86%) in the desoximetasone 0.25% spra …
4-Day evaluation of the irritation potential of topical desoximetasone 0.25% and 0.05% spray on light-exposed skin.
Patel NU, Grammenos A, Gowda A, Onikoyi O, Feldman SR. Patel NU, et al. J Dermatolog Treat. 2018 Jun;29(4):415-417. doi: 10.1080/09546634.2017.1395797. Epub 2017 Nov 9. J Dermatolog Treat. 2018. PMID: 29098908 Clinical Trial.
PURPOSE: The safety and potential side effects of desoximetasone 0.25% and 0.05% sprays have not previously been studied. ...Mean scores of desoximetasone 0.25%, 0.05% and vehicle to non-irradiated treatment areas showed no signs of irritation. ...
PURPOSE: The safety and potential side effects of desoximetasone 0.25% and 0.05% sprays have not previously been studied. ...Mean sco …
Six week evaluation of the potential for topical desoximetasone 0.25% spray to induce photoallergic skin reaction.
Patel NU, Gowda A, Grammenos A, Onikoyi O, Feldman SR. Patel NU, et al. J Dermatolog Treat. 2018 May;29(3):269-271. doi: 10.1080/09546634.2017.1395803. Epub 2017 Nov 9. J Dermatolog Treat. 2018. PMID: 29098900 Clinical Trial.
PURPOSE: Desoximetasone 0.25% topical spray is a novel formulation that has not been tested or approved for safety and efficacy. ...There was statistically significantly greater irritation at the vehicle irradiated site in comparison to the irradiated treatment area of …
PURPOSE: Desoximetasone 0.25% topical spray is a novel formulation that has not been tested or approved for safety and efficacy. ...T …
42 results